BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21625442)

  • 21. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
    Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
    BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
    Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.
    Zhai JM; Yin XY; Hou X; Hao XY; Cai JP; Liang LJ; Zhang LJ
    Dig Dis Sci; 2013 Jul; 58(7):1934-47. PubMed ID: 23625283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
    Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
    Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
    Jiang Z; Jhunjhunwala S; Liu J; Haverty PM; Kennemer MI; Guan Y; Lee W; Carnevali P; Stinson J; Johnson S; Diao J; Yeung S; Jubb A; Ye W; Wu TD; Kapadia SB; de Sauvage FJ; Gentleman RC; Stern HM; Seshagiri S; Pant KP; Modrusan Z; Ballinger DG; Zhang Z
    Genome Res; 2012 Apr; 22(4):593-601. PubMed ID: 22267523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.
    Xu XR; Huang J; Xu ZG; Qian BZ; Zhu ZD; Yan Q; Cai T; Zhang X; Xiao HS; Qu J; Liu F; Huang QH; Cheng ZH; Li NG; Du JJ; Hu W; Shen KT; Lu G; Fu G; Zhong M; Xu SH; Gu WY; Huang W; Zhao XT; Hu GX; Gu JR; Chen Z; Han ZG
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15089-94. PubMed ID: 11752456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.
    Zhang M; Gu J; Zhang C
    Oncotarget; 2016 Feb; 7(7):7780-800. PubMed ID: 26760961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
    Makkoch J; Praianantathavorn K; Sopipong W; Chuaypen N; Tangkijvanich P; Payungporn S
    Asian Pac J Cancer Prev; 2016; 17(2):591-5. PubMed ID: 26925648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
    Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
    J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.